Gleason Group »

Cue Biopharma shares owned by Gleason Group

Quarter-by-quarter ownership of Cue Biopharma (CUE) shares owned by Gleason Group from 13F filings

Historical chart of Gleason Group investment in Cue Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Cue Biopharma held by Gleason Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cue Biopharma by Gleason Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $6.3k 200 31.56

More positions owned by Gleason Group

Vanguard S&p 500 Etf idx (VOO)
Vanguard Total Stock Market ETF (VTI)
Vanguard Extended Market ETF (VXF)
Vanguard Star Fd Intl Stk Idxf (VXUS)
Vanguard Value ETF (VTV)
Vanguard Growth ETF (VUG)
Schwab Strategic Tr us lrg cap etf (SCHX)
Vanguard Mun Bd Fd Inc tax-exempt bd (VTEB)
Vanguard Wellington (VTES)
iShares S&P 1500 Index Fund (ITOT)
Vanguard Intmdte Tm Govt Bd ETF (VGIT)
Vanguard Lg Term Govt Bd ETF (VGLT)
Vanguard Emerging Markets ETF (VWO)
Schwab International Equity ETF (SCHF)
Vanguard High Dividend Yield ETF (VYM)

View all positions for Gleason Group

Top funds holding Cue Biopharma

Belvedere Trading
Robertson Stephens Wealth Management
Angeles Wealth Management
Tidemark
Advisory Services Network
Gleason Group
Mather Group

View all funds holding Cue Biopharma